Inhibitors in Haemophilia A – Ongoing Research and Clinical Practice
Wolfhart Kreuz, Carmen Escuriola-Ettingshausen, Günter Auerswald
Haemophilia A is the most common plasmatic bleeding disorder, caused by congenitally reduced activity of coagulation factor VIII (FVIII). Affected patients suffer from a more or less severe bleeding tendency, mainly in the joints, muscles and organs, which, untreated, leads to haemophilic arthropathy and high mortality. To date, there is no cure for the disease. […]